Literature DB >> 25045406

Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Junling Wang1, Yanru Qiao2, Ya-Chen Tina Shih3, Christina A Spivey4, Samuel Dagogo-Jack5, Jim Y Wan6, Shelley I White-Means7, William C Cushman8, Marie A Chisholm-Burns9.   

Abstract

OBJECTIVE: Medication therapy management (MTM) has the potential to play an instrumental role in reducing racial and ethnic disparities in health care. However, previous research has found that Blacks and Hispanics are less likely to be eligible for MTM. The purpose of the current study was to examine the potential effects of MTM eligibility criteria on racial and ethnic disparities in health outcomes.
METHODS: The current study is a retrospective cross-sectional analysis of the Medicare Current Beneficiary Survey Cost and Use files for the years 2007 and 2008. A difference-in-differences model was used to compare disparities in outcomes between ineligible and eligible beneficiaries according to MTM eligibility criteria in 2010. This was achieved by including in regression models interaction terms between dummy variables for Blacks/Hispanics and MTM eligibility criteria. Interaction terms were interpreted on both multiplicative and additive terms. Various regression models were used depending on the types of variables. KEY
FINDINGS: Whites were more likely to report self-perceived good health status than Blacks and Hispanics among both MTM-eligible and MTM-ineligible populations. Disparities were greater among MTM-ineligible than MTM-eligible populations (e.g., on additive term, difference in odds=1.94 and P<0.01 for Whites and Blacks; difference in odds=2.86 and P<0.01 for Whites and Hispanics). A few other measures also exhibited significant patterns.
CONCLUSIONS: MTM eligibility criteria may exacerbate racial and ethnic disparities in health status and some measures of health services utilizations and costs and medication utilization. Future research should examine strategies to remediate the effects of MTM eligibility criteria on disparities.

Entities:  

Keywords:  Medicare; eligibility criteria; ethnicity; medication therapy management services; race

Year:  2014        PMID: 25045406      PMCID: PMC4100715          DOI: 10.1111/jphs.12055

Source DB:  PubMed          Journal:  J Pharm Health Serv Res        ISSN: 1759-8885


  31 in total

1.  The association of race/socioeconomic status and use of Medicare services. A little-known failure in access to care.

Authors:  M E Gornick
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Authors:  Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins
Journal:  Med Care Res Rev       Date:  2006-12       Impact factor: 3.929

3.  Disparities in health care: minority elders at risk.

Authors:  Lisa Byrd; Audwin Fletcher; Charles Menifield
Journal:  ABNF J       Date:  2007

4.  The impact of Medicare Part D on hospitalization rates.

Authors:  Christopher C Afendulis; Yulei He; Alan M Zaslavsky; Michael E Chernew
Journal:  Health Serv Res       Date:  2011-02-09       Impact factor: 3.402

5.  Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up.

Authors:  Leticia R Moczygemba; Jamie C Barner; Kenneth A Lawson; Carolyn M Brown; Evelyn R Gabrillo; Paul Godley; Michael Johnsrud
Journal:  Am J Geriatr Pharmacother       Date:  2011-08-24

6.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.

Authors:  Ben S Gerber; Young Ik Cho; Ahsan M Arozullah; Shoou-Yih D Lee
Journal:  Am J Geriatr Pharmacother       Date:  2010-04

7.  A framework for the study of access to medical care.

Authors:  L A Aday; R Andersen
Journal:  Health Serv Res       Date:  1974       Impact factor: 3.402

8.  A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.

Authors:  David Fox; L Douglas Ried; Gary E Klein; Wendy Myers; Kristen Foli
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Mar-Apr

9.  Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman
Journal:  Res Social Adm Pharm       Date:  2013-06-10

10.  Racial disparities in prescription drug use among dually eligible beneficiaries.

Authors:  Jennifer Schore; Randall Brown; Bridget Lavin
Journal:  Health Care Financ Rev       Date:  2003
View more
  4 in total

1.  Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Authors:  Junling Wang; Yanru Qiao; Christina A Spivey; Christine Li; Caroline Clark; Yuewen Deng; Flora Liu; Jeffrey Tillman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2016-05-26

2.  Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.

Authors:  Degan Lu; Yanru Qiao; Karen C Johnson; Junling Wang
Journal:  J Asthma       Date:  2016-09-27       Impact factor: 2.515

3.  Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

4.  Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.

Authors:  Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Manag Care Spec Pharm       Date:  2018-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.